Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05161533
Title Hypofractionated Radiation Therapy After Durvalumab and Chemotherapy for the Treatment of Stage IV Extensive Stage Small Cell Lung Cancer, CASPIAN-RT Trial
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Washington
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.